Eqis Capital Management, Inc. Thermo Fisher Scientific Inc. Transaction History

Eqis Capital Management, Inc.

  • $1.17 Billion
  • Q2 2024

A detailed history of Eqis Capital Management, Inc. transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 4,243 shares of TMO stock, worth $2.54 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
4,243
Previous 4,307 1.49%
Holding current value
$2.54 Million
Previous $2.5 Million 6.27%
% of portfolio
0.2%
Previous 0.21%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$541.52 - $599.02 $34,657 - $38,337
-64 Reduced 1.49%
4,243 $2.35 Million
Q1 2024

May 14, 2024
SELL
$528.82 - $599.43 $217,873 - $246,965
-412 Reduced 8.73%
4,307 $2.5 Million
Q4 2023

Feb 14, 2024
SELL
$431.41 - $532.94 $156,170 - $192,924
-362 Reduced 7.12%
4,719 $2.5 Million
Q3 2023

Nov 13, 2023
SELL
$498.29 - $574.41 $1.18 Million - $1.36 Million
-2,361 Reduced 31.73%
5,081 $2.57 Million
Q2 2023

Aug 14, 2023
SELL
$508.46 - $591.13 $266,941 - $310,343
-525 Reduced 6.59%
7,442 $3.88 Million
Q1 2023

May 15, 2023
SELL
$535.0 - $604.82 $465,450 - $526,193
-870 Reduced 9.84%
7,967 $4.59 Million
Q4 2022

Feb 14, 2023
SELL
$484.71 - $571.37 $232,660 - $274,257
-480 Reduced 5.15%
8,837 $4.87 Million
Q3 2022

Oct 24, 2022
BUY
$507.19 - $604.49 $50,719 - $60,449
100 Added 1.08%
9,317 $4.73 Million
Q2 2022

Aug 08, 2022
SELL
$500.9 - $612.21 $1.38 Million - $1.68 Million
-2,750 Reduced 22.98%
9,217 $5.01 Million
Q1 2022

May 16, 2022
BUY
$524.0 - $644.92 $1.55 Million - $1.9 Million
2,951 Added 32.73%
11,967 $7.07 Million
Q4 2021

Feb 14, 2022
BUY
$569.0 - $667.24 $39,830 - $46,706
70 Added 0.78%
9,016 $6.02 Million
Q3 2021

Nov 12, 2021
SELL
$509.53 - $609.78 $623,664 - $746,370
-1,224 Reduced 12.04%
8,946 $5.11 Million
Q2 2021

Aug 12, 2021
BUY
$441.0 - $508.24 $110,691 - $127,568
251 Added 2.53%
10,170 $5.13 Million
Q1 2021

May 14, 2021
SELL
$439.85 - $518.83 $538,376 - $635,047
-1,224 Reduced 10.98%
9,919 $4.53 Million
Q4 2020

Feb 11, 2021
BUY
$435.06 - $527.66 $786,588 - $954,009
1,808 Added 19.37%
11,143 $5.19 Million
Q3 2020

Nov 10, 2020
BUY
$359.77 - $441.52 $59,721 - $73,292
166 Added 1.81%
9,335 $4.12 Million
Q2 2020

Aug 10, 2020
SELL
$275.2 - $362.34 $755,148 - $994,260
-2,744 Reduced 23.03%
9,169 $3.32 Million
Q1 2020

May 12, 2020
SELL
$255.3 - $340.05 $27,317 - $36,385
-107 Reduced 0.89%
11,913 $3.89 Million
Q4 2019

Jan 24, 2020
BUY
$271.93 - $328.04 $53,298 - $64,295
196 Added 1.66%
12,020 $3.91 Million
Q3 2019

Nov 05, 2019
BUY
$268.46 - $305.43 $488,328 - $555,577
1,819 Added 18.18%
11,824 $3.44 Million
Q2 2019

Jul 18, 2019
SELL
$257.51 - $295.55 $583,260 - $669,420
-2,265 Reduced 18.46%
10,005 $2.94 Million
Q1 2019

Apr 18, 2019
BUY
$212.17 - $273.72 $445,344 - $574,538
2,099 Added 20.64%
12,270 $3.36 Million
Q4 2018

Jan 25, 2019
SELL
$208.47 - $251.98 $598,725 - $723,686
-2,872 Reduced 22.02%
10,171 $2.28 Million
Q3 2018

Oct 17, 2018
BUY
$205.57 - $244.32 $813,234 - $966,529
3,956 Added 43.53%
13,043 $3.08 Million
Q2 2018

Jul 27, 2018
SELL
$203.14 - $219.53 $529,179 - $571,875
-2,605 Reduced 22.28%
9,087 $1.88 Million
Q1 2018

Apr 06, 2018
SELL
$192.98 - $224.11 $120,805 - $140,292
-626 Reduced 5.08%
11,692 $2.41 Million
Q4 2017

Jan 25, 2018
SELL
$182.03 - $200.37 $377,348 - $415,367
-2,073 Reduced 14.4%
12,318 $2.34 Million
Q3 2017

Oct 03, 2017
BUY
$171.74 - $194.04 $2.47 Million - $2.79 Million
14,391
14,391 $2.72 Million

Others Institutions Holding TMO

# of Institutions
2,779
Shares Held
340M
Call Options Held
1.42M
Put Options Held
2.15M
View Full List

About THERMO FISHER SCIENTIFIC INC.

TMO Quotes by TradingView
  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $235B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email